However, the limitation of our study is that only one molecular pathway (NRF2/ATF4) was explored, and Sestrin2 may also alleviate PF through other pathways and immune ways, which will be explored in the follow-up studies. This evidence concerns the gene ATF4 and pemphigus foliaceus.